Compare Neurocrine Biosciences Inc (NBIX) vs TKO Group Holdings Inc (TKO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs TKO Group Holdings Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while TKO Group Holdings Inc trades at $181.83 (market cap $13.70B). The key difference: Neurocrine Biosciences Inc is the larger of the two by market cap, and TKO Group Holdings Inc pays a 1.7% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | TKO | |
|---|---|---|
Market Cap | $17.40B | $13.70B |
Sector | Health | Technology |
52-Week High | $180.55 | $224.96 |
52-Week Low | $123.10 | $155.61 |
Enterprise Value | $16.49B | $17.88B |
Dividend Yield | — | 1.7% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About TKO Group Holdings Inc
TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →
